Spectrum Pharmaceuticals, Inc. Shares Fall 2.6% Below Previous 52-Week Low - Market Mover
The shares fell 2.6% higher than its previous 52-week low of $1.54, with trading volume higher than its 30 day average
Nov 30, 2021 by Kwhen Finance Editors
Spectrum Pharmaceuticals, Inc. (SPPI) shares closed 2.6% higher than its previous 52 week low, giving the company a market cap of $259M. The stock is currently down 53.7% year-to-date, down 66.6% over the past 12 months, and down 60.4% over the past five years. This week, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 0.6%.
Trading Activity
- Trading volume this week was 3.8% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.5.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Spectrum Pharmaceuticals, Inc. | -6.5 | -53.7 | -66.6 | ||
| Dow Jones Industrial Average | 0.6 | 16.6 | 19.4 | -3.4 | 21.0 |
| S&P 500 Index | 1.2 | 25.5 | 29.6 | -2.0 | 29.6 |
| Health Care | 0.1 | 16.3 | 21.2 | -3.3 | 21.0 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -7643.3%
- The company's stock price performance over the past 12 months lags the peer average by -322.4%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Spectrum Pharmaceuticals, Inc. | SPPI | 0 | -53.7 | -66.6 | ||
| Peer Avg | N/A | 3.1 | 0.7 | 29.9 | -9.0 | 13.8 |
| Johnson & Johnson | JNJ | 23.5 | 4.1 | 13.7 | -10.3 | 12.1 |
| Pfizer Inc. | PFE | 15.3 | 47.9 | 46.3 | -1.3 | 69.5 |
| Abbott Laboratories | ABT | 31.3 | 18.7 | 20.8 | -4.0 | 21.8 |
| Novartis AG - ADR | NVS | 33.9 | -11.6 | -7.0 | -15.8 | 0.2 |
| Bristol-Myers Squibb Co. | BMY | -22.4 | -9.8 | -10.6 | -19.1 | 2.6 |
| Glaxosmithkline plc - ADR | GSK | 16.0 | 18.9 | 18.0 | -4.2 | 27.9 |
| Biogen Inc | BIIB | 22.4 | -3.6 | -3.1 | ||
| Seagen Inc | SGEN | -90.8 | -5.6 | -2.3 | ||
| Teva- Pharmaceutical Industries Ltd. - ADR | TEVA | 13.1 | -11.0 | -12.5 | -35.6 | 4.0 |
| Curis Inc | CRIS | -11.3 | -40.9 | 236.1 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: